Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1970 2
1971 3
1972 2
1973 3
1974 2
1975 2
1976 2
1977 1
1978 3
1979 3
1980 1
1981 2
1982 1
1983 4
1984 1
1985 4
1987 7
1988 9
1989 8
1990 19
1991 14
1992 20
1993 26
1994 23
1995 32
1996 45
1997 50
1998 29
1999 25
2000 43
2001 39
2002 18
2003 36
2004 41
2005 40
2006 60
2007 45
2008 45
2009 52
2010 61
2011 53
2012 69
2013 81
2014 66
2015 66
2016 57
2017 55
2018 44
2019 36
2020 60
2021 59
2022 55
2023 49
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,470 results

Results by year

Filters applied: . Clear all
Page 1
Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O. Baloch ZW, et al. Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14. Endocr Pathol. 2022. PMID: 35288841 Review.
Follicular cell-derived tumors constitute the majority of thyroid neoplasms. In this new classification, they are divided into benign, low-risk, and malignant neoplasms. ...Anaplastic thyroid carcinoma remains the most undifferentiated form; squ …
Follicular cell-derived tumors constitute the majority of thyroid neoplasms. In this new classification, they are divided into …
Thyroid cancer.
Cabanillas ME, McFadden DG, Durante C. Cabanillas ME, et al. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Lancet. 2016. PMID: 27240885 Review.
Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers hav …
Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with expe …
Management of medullary carcinoma of the thyroid: a review.
Jayasinghe R, Basnayake O, Jayarajah U, Seneviratne S. Jayasinghe R, et al. J Int Med Res. 2022 Jul;50(7):3000605221110698. doi: 10.1177/03000605221110698. J Int Med Res. 2022. PMID: 35822284 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is an uncommon malignancy of neuroendocrine origin derived from the parafollicular C cells. ...
Medullary thyroid carcinoma (MTC) is an uncommon malignancy of neuroendocrine origin derived from the parafollicular C
Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Thomas CM, et al. Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. Epub 2019 Oct 1. Curr Oncol. 2019. PMID: 31708652 Free PMC article. Review.
BACKGROUND: Medullary thyroid carcinoma (mtc) is a rare malignancy of the thyroid gland, and raising awareness of the recommended diagnostic workup and pathologic characteristics of this malignancy is therefore important. ...All patients should undergo …
BACKGROUND: Medullary thyroid carcinoma (mtc) is a rare malignancy of the thyroid gland, and raising awareness o …
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK, Bychkov A, Kakudo K. Jung CK, et al. Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4. Endocrinol Metab (Seoul). 2022. PMID: 36193717 Free PMC article. Review.
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a grading system. ...The terms "follicular nodular disease" and "differentiated high-grade …
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 inclu …
Current Guidelines for Management of Medullary Thyroid Carcinoma.
Kim M, Kim BH. Kim M, et al. Endocrinol Metab (Seoul). 2021 Jun;36(3):514-524. doi: 10.3803/EnM.2021.1082. Epub 2021 Jun 22. Endocrinol Metab (Seoul). 2021. PMID: 34154310 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer. Since the 2015
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnos
Updates on the Management of Thyroid Cancer.
Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Araque KA, et al. Horm Metab Res. 2020 Aug;52(8):562-577. doi: 10.1055/a-1089-7870. Epub 2020 Feb 10. Horm Metab Res. 2020. PMID: 32040962 Free PMC article. Review.
The diagnostic modalities, stratification tools, and treatment options for patients with thyroid cancer have rapidly evolved since the development of the American Thyroid Association (ATA) guidelines in 2015. This review compiles newer concepts in diagnosis, stratif …
The diagnostic modalities, stratification tools, and treatment options for patients with thyroid cancer have rapidly evolved since th …
Medullary thyroid carcinoma.
Jaber T, Dadu R, Hu MI. Jaber T, et al. Curr Opin Endocrinol Diabetes Obes. 2021 Oct 1;28(5):540-546. doi: 10.1097/MED.0000000000000662. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 34292174 Review.
PURPOSE OF REVIEW: To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer (MTC), with a focus on pathogenesis, systemic therapy, and future directions. RECENT FINDINGS: The addition of mutational analysis to cytolo …
PURPOSE OF REVIEW: To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer …
Thyroid Cancer: A Review.
Boucai L, Zafereo M, Cabanillas ME. Boucai L, et al. JAMA. 2024 Feb 6;331(5):425-435. doi: 10.1001/jama.2023.26348. JAMA. 2024. PMID: 38319329 Review.
IMPORTANCE: Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. ...Targeted therapies such as dabrafenib and selpercatinib are directed to genetic mutations (BRAF, RET, NTRK, MEK) that give rise to thyroid cance …
IMPORTANCE: Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. ...Targeted th …
Thyroid Cancer in the Pediatric Population.
Paulson VA, Rudzinski ER, Hawkins DS. Paulson VA, et al. Genes (Basel). 2019 Sep 18;10(9):723. doi: 10.3390/genes10090723. Genes (Basel). 2019. PMID: 31540418 Free PMC article. Review.
This is at least in part due to the underlying biologic and molecular differences between pediatric and adult thyroid cancer. Specifically, papillary thyroid carcinoma (which accounts for approximately 90% of pediatric thyroid cancer) has a high rate o …
This is at least in part due to the underlying biologic and molecular differences between pediatric and adult thyroid cancer. Specifi …
1,470 results